TenSixty Bio
PrivateLast Round
Seed
Aug 24, 2022
Total Funding Raised
$7.2M
Company Overview
TenSixty Bio is a biotechnology company that develops an epitope discovery platform to advance the development of antibody therapeutics for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TenSixty Bio Comparables
Compare TenSixty Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stipple Bio | 78% | |
| Alithea Biotechnology GmbH | 77% | |
| LabGenius Therapeutics | 75% |
TenSixty Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 24, 2022 |
TenSixty Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Engine | Seed |
| General Catalyst | Seed |
| Wing Venture Capital | Seed |
| Civilization Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2022
$7.2M round led by Venture Highway.
TenSixty Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TenSixty Bio's valuation, stock price, and market status.
Is TenSixty Bio a public or private company?
TenSixty Bio is a private company.
What is the current stock price of TenSixty Bio?
TenSixty Bio is a private company with no public stock price. No recent secondary market data is available.
How much is TenSixty Bio worth (valuation)?
Valuation information for TenSixty Bio is not publicly available.
Can I buy TenSixty Bio stock?
TenSixty Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TenSixty Bio's last funding round?
TenSixty Bio's most recent funding round was Seed on August 24, 2022.
Who are the main investors in TenSixty Bio?
Key investors in TenSixty Bio include The Engine, General Catalyst, Wing Venture Capital, Civilization Ventures.
Will TenSixty Bio IPO soon?
No public IPO plans have been announced for TenSixty Bio.
How can I track TenSixty Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TenSixty Bio's secondary market activity and sign up for updates.